Moderate‐to‐severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real‐world experienceLuca Stingeni, Silvia Mariel Ferrucci, Michela Ortoncelli et al.|Journal of the European Academy of Dermatology and Venereology|2022Cited by 60
A 52‐week update of a multicentre Italian real‐world experience on effectiveness and safety of dupilumab in adolescents with moderate‐to‐severe atopic dermatitisLuca Stingeni, Leonardo Bianchi, Elettra Antonelli et al.|Journal of the European Academy of Dermatology and Venereology|2022Cited by 21
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patientsSilvia Ferrucci, Maria Esposito, Simona Tavecchio et al.|Clinical and Experimental Dermatology|2024Cited by 15